Drugs / Ampicillin/sulbactam
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00137007 | Nov 2003 → Sep 2005 | pneumonia | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ampicillin-sulbactam | “The intravenous (IV) regimen containing azithromycin (Zithromax) plus ampicillin-sulbactam is consistent with current guidelines for the treatment of CAP.” NCT00137007 ↗ |
| Modality | Small molecule | “a b-lactam” NCT00137007 ↗ |
| Route | Intravenous | “Intravenous Ampicillin/Sulbactam” NCT00137007 ↗ |